1-8 of 8
Jesse Fishman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Treatment Outcomes of Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated with Pegcetacoplan and Complement Protein 5 Inhibitors (C5i)

Elaine M Majerus, Brian Mulherin, Koo Wilson, Jesse Fishman, Jennifer Mellor, Lucy Earl, Alexander Roeth
Journal: Blood
Blood (2023) 142 (Supplement 1): 5633.
https://doi.org/10.1182/blood-2023-181921
Published: 2023
Journal Articles

A Real-World Evidence Review of Post-Marketing Safety and Compliance with Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the US

Carlos M de Castro, David Dingli, Mohammed Al-Adhami, Brian Mulherin, Michael Yeh, Stacie Lallier, Jesse Fishman
Journal: Blood
Blood (2023) 142 (Supplement 1): 5647.
https://doi.org/10.1182/blood-2023-181917
Published: 2023
Journal Articles

Improvements in Hemoglobin and Cognitive Function from Opera: A Real-World Study of Pegcetacoplan Treatment in US Adults with Paroxysmal Nocturnal Hemoglobinuria

Jesse Fishman, Jinny Min, Lily Arnett, Apeksha Shenoy
Journal: Blood
Blood (2023) 142 (Supplement 1): 5637.
https://doi.org/10.1182/blood-2023-189167
Published: 2023
Journal Articles

Early Experience and Patient Characteristics from Opera: A Real-World Study of Pegcetacoplan Treatment

Jesse Fishman, Jinny Min, Joseph Guarinoni, Katherine Lin
Journal: Blood
Blood (2022) 140 (Supplement 1): 11441–11442.
https://doi.org/10.1182/blood-2022-160242
Published: 2022
Journal Articles

A Matching-Adjusted Indirect Comparison of the Efficacy of Pegcetacoplan Using Prince Trial Data Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria

Raymond Wong, Jesse Fishman, Koo Wilson, Mohammed Al-Adhami, Michael Yeh, Zalmai Hakimi, Christopher Yee, Lynn Huynh, Mei Sheng Duh
Journal: Blood
Blood (2022) 140 (Supplement 1): 11435–11437.
https://doi.org/10.1182/blood-2022-160197
Published: 2022
Journal Articles

Cost per Responder Analysis for Pegcetacoplan and Eculizumab in the Treatment of Adults with Paroxysmal Nocturnal Hemoglobinuria

Seri Anderson, Sandra Talbird, Jesse Fishman
Journal: Blood
Blood (2021) 138 (Supplement 1): 4956.
https://doi.org/10.1182/blood-2021-153190
Published: 2021
Journal Articles

Real-World Ravulizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population

Wendy Y. Cheng, Jesse Fishman, Sujata P. Sarda, Sangeeta Krishnan, Colin Kunzweiler, Jensen Duy Vu, Mihran Yenikomshian, Mei Sheng Duh
Journal: Blood
Blood (2021) 138 (Supplement 1): 4999.
https://doi.org/10.1182/blood-2021-153106
Published: 2021
Journal Articles

Changes in Hemoglobin Measures Observed in PNH Patients Treated with Both C5 Inhibitors Ravulizumab and Eculizumab: Real-World Evidence from a US-Based EMR Network

Michael Yeh, Seth Kuranz, Kaylen Brzozowski, Kate Hoffman, Jesse Fishman, Herman Chen
Journal: Blood
Blood (2021) 138 (Supplement 1): 1112.
https://doi.org/10.1182/blood-2021-151310
Published: 2021